These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38742973)

  • 1. The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Mendiratta-Lala M; Fetzer D; Kamaya A; Parikh ND; Singal AG
    Radiology; 2024 May; 311(2):e232624. PubMed ID: 38742973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC.
    Kim DH; Yoon JH; Choi MH; Lee CH; Kang TW; Kim HA; Ku YM; Lee JM; Kim SH; Kim KA; Lee SL; Choi JI
    J Hepatol; 2024 Sep; 81(3):461-470. PubMed ID: 38636849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance.
    An JY; Peña MA; Cunha GM; Booker MT; Taouli B; Yokoo T; Sirlin CB; Fowler KJ
    Radiographics; 2020; 40(7):1916-1931. PubMed ID: 33136476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
    Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
    JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
    BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision.
    Singal AG; Ng M; Kulkarni A
    J Clin Exp Hepatol; 2024; 14(6):101448. PubMed ID: 38946864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score.
    Truong TN; Pham TND; Hoang LB; Nguyen VT; Dao HV; Dao DVB; Alessy S; Pham HB; Pham TTT; Nguyen LDD; Nguyen K; Abaalkhail F; Manal M; Mawardi M; AlZahrani M; Alswat K; Alghamdi H; Sanai FM; Siddiqui MA; Nguyen NH; Vaidya D; Phan HT; Johnson PJ; Alqahtani SA; Dao DY
    BMC Cancer; 2023 Sep; 23(1):875. PubMed ID: 37723439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study.
    van de Braak C; Willemssen FEJA; de Man RA; van der Lugt A; Uyl-de Groot CA; Bos D; Dwarkasing RS
    Eur Radiol Exp; 2024 Mar; 8(1):29. PubMed ID: 38467990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma.
    Maung ST; Tanpowpong N; Satja M; Treeprasertsuk S; Chaiteerakij R
    J Gastroenterol Hepatol; 2024 Oct; 39(10):1969-1981. PubMed ID: 38899804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
    Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
    Yokoo T; Masaki N; Parikh ND; Lane BF; Feng Z; Mendiratta-Lala M; Lee CH; Khatri G; Marsh TL; Shetty K; Dunn CT; Al-Jarrah T; Aslam A; Davenport MS; Gopal P; Rich NE; Lok AS; Singal AG
    Radiology; 2023 Apr; 307(2):e220917. PubMed ID: 36692401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.
    Brunsing RL; Chen DH; Schlein A; Wolfson T; Gamst A; Mamidipalli A; Vietti Violi N; Marks RM; Taouli B; Loomba R; Kono Y; Sirlin CB
    Radiol Imaging Cancer; 2019 Nov; 1(2):e190010. PubMed ID: 33778680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach.
    Koo E; Singal AG
    Surg Oncol Clin N Am; 2024 Jan; 33(1):13-28. PubMed ID: 37945138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
    Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
    Parikh ND; Tayob N; Singal AG
    J Hepatol; 2023 Jan; 78(1):207-216. PubMed ID: 36089157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
    Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Tools for Hepatocellular Carcinoma Surveillance.
    Singal AG; Reig M; Villanueva A
    Am J Gastroenterol; 2022 Dec; 117(12):1948-1951. PubMed ID: 36114768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.